Massachusetts General Hospital Cancer Center — Boston, Massachusetts

Massachusetts General Hospital Cancer Center is a clinical research site located in Boston, Massachusetts, United States 02114.

Crixeo Health Trust Score: 90/100 (GOOD). This profile has not yet been claimed by the site owner.

Massachusetts General Hospital Cancer Center has participated in 584 clinical trials with 217 currently active.

Therapeutic areas: Colorectal Cancer, Neurofibromatosis Type 1, Plexiform Neurofibroma.

Sponsors: Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI), MacroGenics.

Sponsor Feasibility Report

Trust Score: 90/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Massachusetts General Hospital Cancer Center?

Massachusetts General Hospital Cancer Center has a Crixeo Trust Score of 90/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Massachusetts General Hospital Cancer Center conducted?

Massachusetts General Hospital Cancer Center has 584 clinical trials on record, with 217 currently active. Their work covers Colorectal Cancer, Neurofibromatosis Type 1, Plexiform Neurofibroma.

Is Massachusetts General Hospital Cancer Center accredited by Crixeo Health?

Massachusetts General Hospital Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Massachusetts General Hospital Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.